Stay updated with breaking news from Result Poll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most brokerages see Cipla as the frontrunner of growth within the domestic market in Q1 which will help offset the adverse impact of a moderation in US sales.
Brokerages hint at a weak April-June quarter for chemical companies, marred by pricing pressure, weakening demand and eroding margins.
According to a mean consensus of four brokerage firms, the company is expected to report a Revenue of Rs 17,475 crore in Q1FY24. This is supposed to be a 15.2 percent increase YoY from Rs 15,164 crore reported in Q1FY23.
Market participants will monitor sales volume growth and capacity utilisation during January-March quarter
The market will monitor the NTPC management’s commentary on commercial capacity addition and the timeline for the monetisation of stake in the renewable asset subsidiary